Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with strong diagnostic accuracy.

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Astegolimab met its primary endpoint in the Phase IIb ALIENTO trial with a 15.4% reduction in annualized exacerbation rate at 52 weeks, while the Phase III ARNASA study showed a 14.5% reduction and ...

Your sleep tracker might be more honest than you are. A massive study reveals poor sleep rhythm—not sleep duration—is what ...

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow obstruction plus symptoms of cough, phlegm, and dyspnea or 10 or more ...

Hengrui Pharma has signed an agreement with GSK for the development of up to 12 innovative medicines across several therapeutic areas.

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

For long, Indians have kept cars for decades until they could run no more. As pollution concerns rise, the government is ...

There’s just something about the original Star Trek that connects with you on a very base level. It wasn’t flashy by today’s ...

David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and b ...